Compare CCOI & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCOI | AMPH |
|---|---|---|
| Founded | 1999 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2002 | 2005 |
| Metric | CCOI | AMPH |
|---|---|---|
| Price | $20.32 | $19.52 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 7 |
| Target Price | $29.22 | ★ $30.29 |
| AVG Volume (30 Days) | ★ 1.3M | 567.0K |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | ★ 0.40% | N/A |
| EPS Growth | ★ 11.21 | N/A |
| EPS | N/A | ★ 2.03 |
| Revenue | ★ $975,766,000.00 | $719,887,000.00 |
| Revenue This Year | $11.53 | $7.34 |
| Revenue Next Year | $6.00 | $4.81 |
| P/E Ratio | ★ N/A | $9.75 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.96 | $17.03 |
| 52 Week High | $71.55 | $31.26 |
| Indicator | CCOI | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 45.49 | 35.34 |
| Support Level | $18.97 | N/A |
| Resistance Level | $25.51 | $28.56 |
| Average True Range (ATR) | 1.52 | 1.19 |
| MACD | -0.14 | -0.17 |
| Stochastic Oscillator | 47.37 | 23.93 |
Cogent carries over one-fifth of the world's internet traffic on its network, providing high-capacity services to businesses. Cogent's corporate customers are in high-rise office buildings, where the firm provides two types of connections: dedicated internet access, which connects them to the internet, and virtual private networking, which offers an internal network for employees in different locations. Cogent's corporate customers are exclusively in North America and account for nearly half of the firm's revenue. Cogent's netcentric customers include internet service providers and content providers, to which Cogent provides internet transit. They hand traffic to Cogent in data centers and rely on Cogent to deliver it. About half of netcentric revenue is from outside the US.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.